If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.295    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.01 (3.448%)
Market Cap: £22.94m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Commercial Progress in the Far East

23 Jun 2015 07:00

RNS Number : 8930Q
Haydale Graphene Industries PLC
23 June 2015
 

Haydale Graphene Industries plc

(the "Company" or "Haydale")

 

Commercial Progress in the Far East

 

Haydale (AIM: HAYD), the group focused on the commercialisation of graphene and other nano particle products, is pleased to announce further progress in the Far East, specifically South Korea. These relate to:

 

1. Haydale partners with UK Graphene Exhibit at Nano Korea on 1-3 July 2015

2. Establishing new office in Seoul

 

UK Graphene Exhibit at Nano Korea

 

Haydale is pleased to announce its participation in the UK Graphene Exhibit at NANO KOREA 2015. This is an initiative by leading graphene technology companies, research institutes and government agencies within the UK including Haydale, Thomas Swan & Co. Ltd, 2-DTech Ltd. the Centre for Process & Innovation (CPI), the National Graphene Institute - University of Manchester, the National Physical Laboratory and Innovate UK. The event will be supported by UK Trade & Investment. 

The exhibit will promote the collaborative approach between material and technology providers, world class universities and government backed laboratories and innovation centres between the two regions.

Korea is a major potential market for Haydale's enabling technology. Graphene is regarded as the next "big thing" in Korea and we believe our technology and UK expertise can make a significant impact. Since entering into our sales and marketing agreement with planarTECH in Korea last August we have met a number of progressive Korean companies and this exhibition will further increase our exposure to the nano community in Korea.

The UK Graphene Pavilion will be located at booth A-O25 in hall ABC at NANO KOREA 2015, Coex, Seoul, Korea. http://nanokorea.or.kr/eng/main/

 

Office opening in Seoul

 

Haydale is in the process of establishing a wholly owned subsidiary in Korea, Haydale Technologies (Korea) Co., Ltd, located at Regus Gangnam Station Center in Seoul. Initially the company will be a sales and marketing office managing companies Haydale has been working with and sampling over the last nine months. Thereafter a centre of excellence will be established to include a Haydale reactor offering both functionalisation and advisory services to Far East customers.

 

Commenting on the above, Ray Gibbs, Haydale Chief Executive said:

 

"Our attendance at NANO Korea and the establishment of a new office in Seoul are evidence of Haydale's focus on the key Asian region for the development of new products. This office opening is an exciting strategic development in the push to globalising our enabling technology and is another milestone in the delivery of our strategy to establish centres of excellence across the globe. We are actively working on further initiatives and will announce these as appropriate."

 

- Ends -

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

 

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman, Will Goode (Corporate Finance)

David Banks, Tessa Sillars (Corporate Broking)

 

 

Hermes Financial PR

 

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

About Haydale ( www.haydale.com )

Haydale has developed a patent pending proprietary scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a low pressure plasma process that treats both organic mined fine powder and other synthetically produced nanomaterial powders producing high quality few layered graphenes and graphene nano platelets. The process can functionalise with a range of chemical groups, where the amount of chemicals can be tailored to the customer needs. Good dispersion improves the properties and performance of the host material and ensures it delivers as specified.

The Haydale plasma process does not use wet chemistry, neither does it damage the material being processed, rather it can clean up impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale method is an enabling technology where working with a raw material producer can add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales, housed in a purpose built facility for processing and handling nanomaterials with a laboratory facility, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, photovoltaics, composites, paints and coatings.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABLLLLEQFBBBB
Date   Source Headline
24th Jun 20267:00 amRNSInterim Results
11th Jun 20267:00 amRNSContract Win
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.